Skip to content

13F-HR filed by Atle Fund Management AB

Atle Fund Management AB filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-05, with 17 holding rows worth $150,999,000.

Accession
0001381843-21-000002
Filed
2021-02-05
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 17 entries on the cover page, a total value of $150,999,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $150,999,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SUPERNUS PHARMACEUTICALS868459108COM465,000$11,699,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM600,000$10,428,000thousands by filing date
VIATRIS INC COM92556V106Stock525,000$9,839,000thousands by filing date
Cigna Corporation125523100COM47,000$9,784,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM480,000$9,614,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK835,000$9,511,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock68,000$9,350,000thousands by filing date
AbbVie,Inc.00287Y109COM87,000$9,322,000thousands by filing date
MCKESSON CORP COM58155Q103Stock53,000$9,218,000thousands by filing date
CENCORA INC COM03073E105Stock93,000$9,092,000thousands by filing date
Bristol-Myers Squibb Company110122108COM146,000$9,056,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM169,000$9,052,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR915,000$8,830,000thousands by filing date
ACCURAY INC DEL004397105COM1,650,000$6,881,000thousands by filing date
ANTARES PHARMA INC036642106COM1,720,000$6,863,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM1,575,000$6,615,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM1,750,000$5,845,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001381843-21-000002this filing2021-02-05acceptance time not in the bulk data set